DaVita Inc. Files Q1 2025 10-Q

Ticker: DVA · Form: 10-Q · Filed: 2025-05-12T00:00:00.000Z

Sentiment: neutral

Topics: 10-Q, healthcare, finance, debt

TL;DR

DaVita's Q1 2025 10-Q is in. Check financials and debt.

AI Summary

DaVita Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and operational aspects of the company, which operates in the healthcare services sector, specifically focusing on kidney dialysis. Key financial figures and debt obligations are presented, alongside executive information such as James O. Hearty's role as Chief Compliance Officer.

Why It Matters

This filing provides investors and analysts with the latest financial performance and disclosures for DaVita Inc., a major provider of kidney dialysis services, impacting understanding of the company's health and market position.

Risk Assessment

Risk Level: medium — The filing contains detailed financial information, including debt obligations, which are critical for assessing the company's financial health and associated risks.

Key Numbers

5,000 — Shares (Likely related to share count or options, context unclear without full table.)
450,000 — Shares (Likely related to share count or options, context unclear without full table.)
77,277 — Amount (Financial figure, context unclear without full table.)
80,536 — Amount (Financial figure, context unclear without full table.)
90,770 — Amount (Financial figure, context unclear without full table.)

Key Players & Entities

DAVITA INC. (company) — Filer of the 10-Q
20250331 (date) — Period of report for the 10-Q
James O. Hearty (person) — Chief Compliance Officer
510354549 (company) — EIN for DaVita Inc.
001-14106 (company) — SEC File Number for DaVita Inc.

FAQ

What were DaVita's total revenues for the first quarter of 2025?

The provided text does not explicitly state the total revenues for the first quarter of 2025. It contains various numerical data points but lacks a clear revenue figure for the period.

What is the maturity date for the $1,250,000 debt?

The filing indicates a debt of $1,250,000 with a maturity date of 12/31/2025.

Who is James O. Hearty and what is his role?

James O. Hearty is identified as the Chief Compliance Officer for DaVita Inc.

When was DaVita Inc. formerly known as Total Renal Care Holdings Inc.?

DaVita Inc. was formerly known as Total Renal Care Holdings Inc. prior to a name change on 19950524.

What is the SEC file number for DaVita Inc.?

The SEC file number for DaVita Inc. is 001-14106.

From the Filing

0000927066-25-000087.txt : 20250512 0000927066-25-000087.hdr.sgml : 20250512 20250512170210 ACCESSION NUMBER: 0000927066-25-000087 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250512 DATE AS OF CHANGE: 20250512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 25935860 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 10-Q 1 dva-20250331.htm 10-Q dva-20250331 false 2025 Q1 0000927066 12/31 0.001 5,000 — 0.001 450,000 77,277 80,536 90,770 90,369 not 2,000,000 3.75 6/30/2024 12/31/2025 1,250,000 1,000,000 4.00 6/30/2024 12/31/2025 750,000 500,000 4.50 6/30/2024 12/31/2026 500,000 250,000 4.50 12/31/2024 12/31/2025 250,000 750,000 4.00 12/31/2024 12/31/2026 250,000 500,000 1,750,000 12/31/2025 12/31/2027 750,000 1,000,000 750,000 12/31/2025 12/31/2027 250,000 500,000 1,000,000 12/31/2026 12/31/2028 250,000 750,000 five years James O. Hearty Chief Compliance Officer 4535 3/17/2025 11/30/2025 259 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 0000927066 2025-01-01 2025-03-31 0000927066 2025-05-09 0000927066 2024-01-01 2024-03-31 0000927066 2025-03-31 0000927066 2024-12-31 0000927066 2023-12-31 0000927066 2024-03-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2024-12-31 0000927066 us-gaap:CommonStockMember 2024-12-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000927066 us-gaap:RetainedEarningsMember 2024-12-31 0000927066 us-gaap:TreasuryStockCommonMember 2024-12-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000927066 us-gaap:ParentMember 2024-12-31 0000927066 us-gaap:NoncontrollingInterestMember 2024-12-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2025-01-01 2025-03-31 0000927066 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000927066 us-gaap:ParentMember 2025-01-01 2025-03-31 0000927066 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0000927066 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000927066 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2025-03-31 0000927066 us-gaap:CommonStockMember 2025-03-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000927066 us-gaap:RetainedEarningsMember 2025-03-31 0000927066 us-gaap:TreasuryStockCommonMember 2025-03-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000927066 us-gaap:ParentMember 2025-03-31 0000927066 us-gaap:NoncontrollingInterestMember 2025-03-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2023-12-31 0000927066 us-gaap:CommonStockMember 2023-12-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000927066 us-gaap:RetainedEarningsMember 2023-12-31 0000927066 us-gaap:TreasuryStockCommonMember 2023-12-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000927066 us-gaap:ParentMember 2023-12-31 0000927066 us-gaap:NoncontrollingInterestMember 2023-12-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInt